Concepedia

Bodo Junge

BJ

5

Publications

1K

Citations

5

H-Index

1977

Active since

Affiliations

Bayer (Germany)(Current)

Bodo Junge is an author at Bayer (Germany) specializing in medicine, drug discovery, and pharmacology.

Top concepts

MedicineBiochemistryPharmacologyDrug DiscoveryPharmacotherapyNatural SciencesMedicinal ChemistryMolecular PharmacologyBiomolecular EngineeringGlycobiology

Publications per year

1977–1993

5

Publications

5

Chemistry and Biochemistry of Microbial α‐Glucosidase Inhibitors

Ernst Truscheit, Werner Frommer, Bodo Junge et al. · Angewandte Chemie International Edition in English · 1981 · 473 citations

Metabolic Pathways, Microbial α‐Glucosidase Inhibitors, Abstract α‐Glucosidases +11

?-Glucosidase inhibitors

Delf Schmidt, Wolf B. Frommer, Bodo Junge et al. · Die Naturwissenschaften · 1977 · 468 citations

In vitro pharmacology of BAY X1005, a new inhibitor of leukotriene synthesis

R. Fruchtmann, Klaus Mohrs, Armin Hatzelmann et al. · Inflammation Research · 1993 · 47 citations

Molecular Pharmacology, Bay X1005, Medicine +8

Reaction of 1‐α‐Cyano‐1‐deoxynojirimycin with Grignard Compounds—Complete Exchange of the CN— Group

Horst Böshagen, Walter Geiger, Bodo Junge · Angewandte Chemie International Edition in English · 1981 · 22 citations

Medicinal Chemistry, 1-Deoxynojirimycin Derivatives, Bioorganic Chemistry +15

BAY X1005, a new selective inhibitor of leukotriene synthesis: pharmacology and pharmacokinetics.

R. Müller‐Peddinghaus, R. Fruchtmann, H J Ahr et al. · PubMed · 1993 · 15 citations

Bay X1005, Lipid Peroxidation, New Selective Inhibitor +16

Rows per page

1–5 of 5